By investigating the existence of an unusual four-stranded structure of DNA in human cells, scientists have opened the door to novel cancer therapeutics and a new era for personalised medicine.
Researchers have identified 10 different types of the disease, laying groundwork for more effective, targeted treatment plans.
New discoveries by Cambridge scientists about a molecular waste-disposal process that ‘eats’ bacteria are influencing the clinical management of cystic fibrosis, and could be the basis of innovative new treatments to fight off bacteria.
<p>Research paves way for new liver disease research and possibly cell-based therapy.<br /> &nbsp;
A new generation of cancer therapeutics is on the horizon thanks to fresh light being shed on how genes are switched on and off.
Fundamental research is pioneering innovative approaches to cancer diagnosis and treatment at the Hutchison/MRC Research Centre.
The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.
Some remarkable organisms are able to withstand almost complete desiccation. How they survive is providing Cambridge researchers with new ideas for biostable therapeutics.
The way a common virus hijacks the cell it infects could hold the clue to combating Parkinson's disease.
The first Asian and African human genomes have been deciphered using a technique originally invented by Professors Shankar Balasubramanian and David Klenerman at the University of Cambridge's Department of Chemistry and developed by the spin-out Solexa.
© 2024 University of Cambridge